Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: Prognostic value of circumferential resection margin and stratification of N1 category

Annals of Surgical Oncology

Volumn 16, Issue 5, 2009, Pages 1364-1370

  Saha, Arin Kumar ^a   Sutton, Christopher ^a   Rotimi, Olorunda ^b   Dexter, Simon ^a   Sue Ling, Henry ^a   Sarela, Abeezar I ^a  

^a St James's Institute of Oncology ^*  (United Kingdom)

^b ST JAMES S INSTITUTE OF ONCOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG WITHDRAWAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROTOMY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PREOPERATIVE TREATMENT; PROGNOSIS; SURGICAL MORTALITY; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 64249152746     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0396-6     Document Type: Article

References (35)

1. CC Compton LP Fielding LJ Burgart 2000 Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 124 7 979 994
2. PL Fitzgibbons DL Page D Weaver 2000 Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 124 7 966 978
3. G Garcea AR Dennison CJ Pattenden 2008 Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature JOP 9 2 99 132
4. AP Barbour NP Rizk M Gonen 2007 Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome Ann Surg. 246 1 1 8
5. IJ Adam MO Mohamdee IG Martin 1994 Role of circumferential margin involvement in the local recurrence of rectal cancer Lancet. 344 8924 707 711
6. PM Sagar D Johnston MJ McMahon 1993 Significance of circumferential resection margin involvement after oesophagectomy for cancer Br J Surg 80 11 1386 1388
7. SP Dexter H Sue-Ling MJ McMahon 2001 Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer Gut 48 5 667 670
8. Dataset for the histopathological reporting of oesophageal carcinoma, 2nd edn. Document G006. The Royal College of Pathologists. February 2007.
9. Surgical Pathology Cancer Case Summary (Checklist): Esophagus. College of American Pathologists. January 2005.
10. Medical Research Council Oesophageal Cancer Working Group 2002 Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial Lancet 359 9319 1727 1733
11. AI Sarela S Yelluri Leeds Upper Gastrointestinal Cancer Multidisciplinary Team 2007 Gastric adenocarcinoma with distant metastasis: is gastrectomy necessary? Arch Surg 142 2 143 149
12. Medical Research Council OE05 Clinical Protocol, Version 3, September 2005.
13. AM Mandard F Dalibard JC Mandard 1994 Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer 73 11 2680 2686
14. N Rizk E Venkatraman B Park 2006 The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system J Thorac Cardiovasc Surg 132 6 1374 1381
15. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481
16. P Therasse SG Arbuck EA Eisenhauer 2000 New guidelines to evaluate the response to treatment in solid tumors European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 3 205 216
17. DP Kelsen R Ginsberg TF Pajak 1998 Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med 339 27 1979 1984
18. TM Pawlik D Laheru RH Hruban 2008 Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer Ann Surg Oncol 15 2081 2088
19. AI Sarela DJ Tolan K Harris 2008 Anastomotic leakage after esophagectomy for cancer: a mortality-free experience J Am Coll Surg 206 3 516 523
20. JD Hayden HM Sue-Ling AI Sarela 2007 Minimally invasive management of chylous fistula after esophagectomy Dis Esophagus 20 3 251 255
21. N Altorki D Skinner 2001 Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg 234 5 581 587
22. CS Verbeke KV Menon 2008 Variability in reporting resection margin status in pancreatic cancer Ann Surg 247 4 716 717
23. V Sujendran J Wheeler R Baron 2008 Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer Br J Surg 95 2 191 194
24. BH Burmeister BM Smithers V Gebski 2005 Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Lancet Oncol 6 9 659 668
25. NP Rizk E Venkatraman MS Bains 2007 American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma J Clin Oncol 25 5 507 512
26. EA Griffiths Z Brummell G Gorthi 2006 The prognostic value of circumferential resection margin involvement in oesophageal malignancy Eur J Surg Oncol 32 4 413 419
27. NR Hall PJ Finan T al-Jaberi 1998 Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum 41 8 979 983
28. AJCC Cancer Staging. 6th ed. New York: Springer; 2002.
29. A Rullier C Laurent M Capdepont 2008 Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival Am J Surg Pathol 32 1 45 50
30. E Bollschweiler SE Baldus W Schröder 2006 Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes Are these independent prognostic factors? J Surg Oncol 94 5 355 363
31. RJ Korst VW Rusch E Venkatraman 1998 Proposed revision of the staging classification for esophageal cancer J Thorac Cardiovasc Surg 115 3 660 669
32. JA Hagen SR DeMeester JH Peters 2001 Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies Ann Surg 234 4 520 530
33. W Hofstetter AM Correa N Bekele 2007 Proposed modification of nodal status in AJCC esophageal cancer staging system Ann Thorac Surg 84 2 365 373
34. Y Gu SG Swisher JA Ajani 2006 The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation Cancer 106 5 1017 1025
35. D Bogoevski F Onken A Koenig 2008 Is it time for a new TNM classification in esophageal carcinoma? Ann Surg 247 4 633 641